IMMSTAT

Welcome to the Brand page for “IMMSTAT”, which is offered here for Chemical medical reagents for use in gene therapy; pharmaceutical preparations for use in gene therapy; therapeutic compositions containing liposome reagents suitable for gene therapy; therapeutic compositions containing nucleic acids, viral vectors or non viral vectors for gene therapy; pharmaceutical preparations containing nucleic acids, viral vectors or non viral vectors for use in the treatment of viral and bacterial infections, cancer, hiv and aids related infections, neurodegenerative disorders, diseases of the eye which result in vision impairment or loss, diseases of the ear which result in hearing impairment or loss, and bodily conditions associated with impaired immune systems; pharmaceutical preparations in the field of gene therapy; pharmaceutical preparations for the treatment of viral and bacterial infections, cancer, hiv and aids related infections, neurodegenerative disorders, diseases of the eye which result in vision impairment or loss, diseases of the ear which result in hearing impairment or loss, and bodily conditions associated with impaired immune systems;instruments and apparatus for the administration of gene therapy products, syringes, injectors, scalpels, catheters, indwelling catheters, pumps, tubes for the administration of gene therapy products; surgical instruments for the administration of gene therapy products;.

Its status is currently believed to be active. Its class is unavailable. “IMMSTAT” is believed to be currently owned by “Oxford BioMedica plc”.